BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Puxeddu E, Rogliani P. Prognostic scoring systems for clinical course and survival in idiopathic pulmonary fibrosis. World J Respirol 2016; 6(1): 14-23 [DOI: 10.5320/wjr.v6.i1.14]
URL: https://www.wjgnet.com/2218-6255/full/v6/i1/14.htm
Number Citing Articles
1
Tejaswini Kulkarni, Kaiyu Yuan, Thi K. Tran-Nguyen, Young-il Kim, Joao A. de Andrade, Tracy Luckhardt, Vincent G. Valentine, Daniel J. Kass, Steven R. Duncan, James West. Decrements of body mass index are associated with poor outcomes of idiopathic pulmonary fibrosis patientsPLOS ONE 2019; 14(10): e0221905 doi: 10.1371/journal.pone.0221905
2
Ingrid A. Cox, Julie Campbell, Barbara de Graaff, Petr Otahal, Tamera J. Corte, Yuben Moodley, Peter Hopkins, Sacha Macansh, E. Haydn Walters, Andrew J. Palmer. Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8DQuality of Life Research 2023; 32(2): 473 doi: 10.1007/s11136-022-03205-z
3
Ingrid A. Cox, Barbara de Graaff, Hasnat Ahmed, Julie Campbell, Petr Otahal, Tamera J. Corte, Yuben Moodley, Nicole Goh, Peter Hopkins, Sacha Macansh, E. Haydn Walters, Andrew J. Palmer. The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness studyThe European Journal of Health Economics 2023; 24(7): 1121 doi: 10.1007/s10198-022-01538-7
4
Ingrid A. Cox, Barbara de Graaff, Hasnat Ahmed, Julie Campbell, Petr Otahal, Tamera J. Corte, Ian Glaspole, Yuben Moodley, Nicole Goh, Sacha Macansh, E. Haydn Walters, Andrew J. Palmer. The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from AustraliaQuality of Life Research 2021; 30(9): 2615 doi: 10.1007/s11136-021-02879-1